A Microfluidic Cartridge-Based Detection System for Allergen-Specific Immunoglobulin E
JoVE Encyclopedia of Experiments
Immunology
0 views • 3:31 min • July 8th, 2025
Begin with a microfluidic cartridge equipped with storage tanks and unidirectional pumps that deliver reagents through channels into a reaction zone.
The reaction zone contains multiple spots immobilized with distinct allergens.
Load wash buffer, blocking buffer, peroxidase-conjugated secondary antibodies, and a chemiluminescent peroxidase substrate into the designated tanks.
Add a serum sample containing allergen-specific immunoglobulin E or IgE.
Initiate the analysis inside a chemiluminescence analyzer.
Within the reaction zone, the blocking buffer flows and blocks non-specific interaction sites.
The introduction of serum allows the IgEs to interact with the immobilized allergens.
Washing eliminates unbound IgEs.
Next, peroxidase-conjugated secondary antibodies flow in and interact with the immobilized IgEs.
Subsequent washing removes unbound antibodies.
The analyzer then introduces the chemiluminescent substrate and hydrogen peroxide .
The peroxidase oxidizes the substrate, emitting luminescence .
The luminescence intensity in each spot provides a quantifiable indication of distinct allergen-specific IgEs in the serum.
To test serum samples for serum immunoglobulin E antibodies to whole allergens, randomly select three samples with at least 900 microliters of serum, and take the chip from the kit, and number it. Then, turn on the computer and the analyzer power. Start the LabIT program on the computer.
If the dark frame warning window pops up, click OK to run a leak test. Then, click the center logo to enter the operation interface. Check the reaction temperature and the charge-coupled device or CCD temperature. The reaction temperature should rise to 37 plus or minus 1 degrees Celsius in about 10 minutes, and the CCD temperature should drop to minus 15 plus or minus 1 degrees Celsius.
When the CCD temperature has dropped to minus 15 plus or minus 1 degrees Celsius, confirm that there are no other items left inside the instrument and close the door. Then click Tools, System Test, Leak Test. When the test is finished, the report window will pop up.
Next, load 620 microliters of wash buffer, 120 microliters of blocking buffer, 60 microliters of conjugates A and B, 60 microliters of substrates A and B, and 100 microliters of each serum sample into the corresponding reagent tanks on the microfluidic cartridge. After clicking cartridge ID, use the barcode scanner to scan the serial number of the cartridge and enter the sample ID. Then, place the cartridge into the analyzer, close the door, and click analyzer, and run to start the analysis.
Overview
This article describes a microfluidic method for analyzing allergen-specific immunoglobulin E (IgE) in serum samples. The process involves using a cartridge with various reagents and a chemiluminescence analyzer to quantify IgE levels.
Key Study Components
Area of Science
- Immunology
- Microfluidics
- Allergen analysis
Background
- IgE plays a crucial role in allergic reactions.
- Quantifying IgE can help in diagnosing allergies.
- Microfluidic technologies enable precise and efficient analysis.
- This method allows for simultaneous testing of multiple allergens.
Purpose of Study
- To develop a reliable method for measuring allergen-specific IgE.
- To enhance the efficiency of allergy testing.
- To utilize microfluidic technology for improved analysis.
Methods Used
- Microfluidic cartridge with storage tanks and pumps.
- Use of blocking and wash buffers to minimize non-specific interactions.
- Introduction of serum samples containing IgE.
- Chemiluminescence detection to quantify IgE levels.
Main Results
- Successful quantification of allergen-specific IgEs in serum samples.
- Demonstrated efficiency of the microfluidic method.
- Provided a clear protocol for allergen testing.
- Results indicate potential for clinical application in allergy diagnostics.
Conclusions
- The microfluidic approach is effective for allergen-specific IgE analysis.
- This method can streamline allergy testing processes.
- Future studies may expand on this technology for broader applications.
Frequently Asked Questions
Executive Industry Relevance
This microfluidic cartridge-based system enables high-throughput, multiplexed detection of allergen-specific IgE, supporting early-stage target validation in allergy therapeutics by providing quantitative, reproducible biomarker measurements. The chemiluminescence readout delivers predictive confidence in IgE-allergen interaction strength, facilitating go/no-go decisions in lead identification pipelines. By standardizing immunoassay workflows, the platform reduces biological noise and enhances translational continuity from discovery to preclinical evaluation.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses by quantifying allergen-specific IgE binding to immobilized antigens.
- Operational Value: Supports biological de-risking through reproducible, multiplexed IgE profiling across allergen panels.
- Strategic Value: Generates predictive confidence for target prioritization by correlating IgE levels with allergen reactivity.
Screening & Assay Development
- Scientific Value: Prepares validated biological systems for downstream screening by defining allergen-specific IgE thresholds.
- Operational Value: Ensures assay standardization via cartridge-based reagent delivery and controlled reaction zones.
- Strategic Value: Enhances screening readiness through simultaneous multi-allergen detection and scalable cartridge reuse.
Translational & Preclinical Research
- Scientific Value: Aligns with translational biomarker strategies by quantifying IgE as a functional readout of allergic response.
- Operational Value: Maintains continuity from discovery through preclinical validation using consistent immunoassay format.
- Strategic Value: Supports risk-adjusted advancement decisions by providing quantitative IgE data for efficacy and safety assessment.
Pipeline & Workflow Integration
The method integrates into the discovery continuum from early target validation through lead identification, enabling quantitative biomarker measurement that informs compound selection and mechanistic de-risking.
- Discovery Biology: Supports hypothesis testing by measuring allergen-specific IgE interactions in a controlled microfluidic environment.
- Screening: Delivers assay readiness through standardized reagent loading and chemiluminescent output generation.
- Analytics: Provides quantitative luminescence measurements that enable comparison of IgE levels across allergen spots and sample conditions.
- Translational Research: Connects to preclinical continuity by offering a reproducible IgE detection method applicable to disease-relevant models.
- Enterprise Reuse: Functions as a reusable platform for immunoassay development across multiple allergen targets and sample types.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence in target validation, reduction of mechanistic ambiguity in IgE-allergen interactions.
- Operational Value: Standardization, reproducibility, and scalability of multiplexed immunoassays.
- Strategic Value: Better go/no-go decisions, capital efficiency, and reduced late-stage biological risk in allergy therapeutic development.
- Portfolio Impact: Risk-adjusted prioritization and advancement decisions based on quantitative IgE profiling.
Implementation Considerations
- Requires expertise in immunoassay design and microfluidic system operation.
- Dependent on chemiluminescence analyzer and temperature-controlled instrumentation.
- Necessitates cross-team standardization of reagent loading and cartridge handling procedures.
- Involves adaptation considerations for different allergen panels and sample matrices.
- Practical limitations include reagent stability and cartridge shelf life as noted in source protocol.
Biopharma FAQs
A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
Related Videos
0 Views
Basophil Activation Test for Allergy Diagnosis
Related Videos
0 Views
Humanized Mediator Release Assay as a Read-Out for Allergen Potency
Related Videos
0 Views
Murine Model of Allergen Induced Asthma
Related Videos
0 Views
A Paper-Based Immunoassay for the Detection of Immunoglobulin G
Related Videos
0 Views
A Magnetic Nanoparticle-Based Immunoassay Using a Microfluidic Device
Related Videos
0 Views
Detection of True IgE-expressing Mouse B Lineage Cells
Related Videos
0 Views
Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies
Related Videos
0 Views
Flow Cytometric Analysis of Particle-bound Bet v 1 Allergen in PM10
Related Videos
0 Views
Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Related Videos
0 Views
Last updated: 22 August 2026